Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 20, 2026
TickeronGET DAILY SIGNALS
MRX vs SNEX: Why Marex Group's Steadier Climb Stands Out

MRX vs SNEX: Why Marex Group's Steadier Climb Stands Out

Key Takeaways

  • Tickeron AI Verdict: Based on trend consistency, relative stability, and fewer recent negative catalysts, MRX is the ticker favored in this comparison.
  • Marex Group (MRX) and StoneX Group (SNEX) both operate in commodity, derivatives, and financial-market clearing and execution, but differ in scale, geographic mix, and growth drivers.
  • MRX has delivered a steadier, more sustained uptrend over the past year, while SNEX has posted stronger absolute gains but with significantly higher volatility and a sharp recent pullback after an earnings shortfall.
  • SNEX reported record full-year results yet saw a steep single-session selloff after its quarterly earnings per share (EPS) missed estimates, underscoring how much the market had already priced in.
  • Explore additional context on MRX Major News and MRX Today's Price Move, as well as SNEX Major News and SNEX Today's Price Move.
  • For automated, data-driven market ideas, explore the curated Trending AI Robots.

Setting the Stage for This Comparison

Marex Group (MRX) and StoneX Group (SNEX) are two publicly traded financial-services platforms that sit at the intersection of commodities, derivatives, and global market access. Both generate revenue from execution, clearing, market making, and client-balance interest, making them natural peers for investors evaluating the brokerage and capital-markets sector. This stock comparison is most relevant to traders and investors weighing relative performance, business-model trade-offs, and market positioning between two firms that thrive on trading volumes, volatility, and client activity. By examining recent momentum, risk factors, and valuation, this article offers a balanced view of how the two names currently stack up.

Marex Group (MRX) at a Glance

Marex Group Limited (MRX) is a U.K.-headquartered financial-services platform that provides liquidity, market access, and infrastructure to clients across commodity and financial markets. Its operations span clearing, agency and execution, market making, and hedging and investment solutions, with a notable presence in metals, agriculture, energy, and fixed income. The company completed its initial public offering (IPO) in April 2024 and has since attracted attention for strong top-line growth and profitability.

In recent market activity, MRX has traded well above its 52-week low while consolidating below its recent highs, reflecting a stock that has climbed substantially over the past year but cooled in recent weeks. Investor sentiment has been supported by robust revenue expansion and earnings growth, while a relatively modest price-to-earnings (P/E) multiple and a small dividend yield have added to its appeal among value-conscious investors. Profit-taking and broader sector rotation appear to have contributed to a mild pullback, but the company's fundamental trajectory has remained intact. I also checked this using Tickeron’s AI Trend Prediction Engine to confirm the steadier pattern.

StoneX Group (SNEX) at a Glance

StoneX Group Inc. (SNEX) is a New York-based diversified financial-services network connecting clients to markets across the United States, Europe, South America, the Middle East, and Asia. It operates through Commercial, Institutional, Self-Directed/Retail, and Payments segments, offering commodity trading, risk management, securities brokerage, foreign exchange (FX), and cross-border payments. Its scale was expanded further by the acquisition of R.J. O'Brien's global business.

SNEX has been among the sector's strongest performers over the past year, with shares rising sharply before peaking in mid-2026. In recent weeks, however, the stock has experienced meaningful volatility. The company reported record full-year results, including a roughly 72% increase in net income, but its latest quarterly EPS of $0.66 fell short of consensus estimates, triggering a steep single-session decline. Rising expenses, narrowing securities spreads, and a higher effective tax rate pressured the quarter, even as the Commercial and Payments segments delivered notable growth. This contrast between strong annual results and a soft quarterly finish has reshaped near-term sentiment. I also checked this using Tickeron’s AI Pattern Search Engine to review recent moves.

Side-by-Side Comparison

While both companies profit from market access and trading activity, their profiles differ in important ways. Marex (MRX) skews toward commodities and derivatives execution and clearing with a strong European base, whereas StoneX (SNEX) operates a broader, more diversified network spanning physical commodities, securities, FX, and payments across multiple continents. SNEX's scale and diversification have historically supported higher absolute earnings, but its greater complexity also introduces more moving parts in any given quarter.

On momentum, both names have delivered strong trailing-year gains, but their recent paths diverge. MRX has exhibited a steadier, less volatile climb, while SNEX surged more aggressively before a sharp correction following its earnings miss. On valuation, MRX trades at a comparatively modest P/E, while SNEX's premium had expanded before the recent selloff. Risk factors also differ: SNEX faces integration and expense-management considerations tied to acquisitions, whereas MRX's exposure is more concentrated in commodities and rate-sensitive client balances. From a sentiment standpoint, MRX's relative stability currently contrasts with SNEX's elevated uncertainty following its quarterly shortfall.

Tickeron AI Verdict

Based on observable factors, Tickeron's AI would likely favor MRX in the current environment. The reasoning centers on relative trend consistency and stability: MRX has maintained a more orderly advance with less severe drawdown, while SNEX's recent earnings-driven volatility introduces greater uncertainty in the near term. MRX's steadier price behavior, comparatively modest valuation, and absence of a fresh negative catalyst give it a probabilistic edge on a risk-adjusted basis. That said, SNEX retains a fundamentally strong business with record annual results, and its pullback could be viewed differently as conditions evolve. The verdict reflects a current, data-driven lean toward MRX rather than a definitive or permanent judgment.

Using AI Tools in My Research Process

One resource I turn to when comparing names like these is Tickeron’s Trending AI Robots. The platform curates bots with strong, measurable track records across different market conditions, offering a focused way to explore automated strategies that align with current dynamics. It helps narrow options without sifting through thousands of possibilities, which I find practical for staying objective in relative-value work.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SNEX, MRX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


SNEX sees MACD Histogram crosses below signal line

SNEX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In 31 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SNEX as a result. In 52 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

The Aroon Indicator for SNEX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for SNEX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +5.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNEX advanced for three days, in 268 of 357 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

SNEX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. SNEX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.

The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.303) is normal, around the industry mean (3.143). P/E Ratio (13.934) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.976) among similar stocks. P/S Ratio (0.054) is also within normal values, averaging (17.075).

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 11.61B. The market cap for tickers in the group ranges from 590 to 284.96B. MS holds the highest valuation in this group at 284.96B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was -8%. For the same Industry, the average monthly price growth was -21%, and the average quarterly price growth was -30%. NCPL experienced the highest price growth at 90%, while SOS experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 42%. For the same stocks of the Industry, the average monthly volume growth was 20% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 65
Price Growth Rating: 71
SMR Rating: 74
Profit Risk Rating: 88
Seasonality Score: -2 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the provision of brokerage and financial services

Industry InvestmentBanksBrokers

Industry
N/A
Address
230 Park Avenue
Phone
+1 212 485-3500
Employees
5400
Web
https://www.stonex.com
Interact to see
Advertisement
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.